The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / R••••••• B••••••

R••••••• B•••••• Announces Closing of Growth Investment from C••••• a•• C•••• E•••••••• O•••••• T•••••••••

Growth investmentannouncedannounced Mar 16, 2022Fact
What happened
Target
R••••••• B••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
Unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
8 named
Buy side
  • C••••• S••Sponsorconfirmed
    “R••••••• B•••••• ("R•••••••" or the "Company"), an industry- leading provider of drug discovery services, today announced the closing of a significant investment from C•••••, an international private equity firm, to fuel the Company's continued growth and service line expansion.”
Sell side
Financing side
  • G•••• C••••••Lenderconfirmed
    “G•••• C•••••• provided financing for the transaction.”
Advisory side
  • P•••• S•••••• L•••Buy-side adviserconfirmed
    “W•••••• B•••• & Co. acted as exclusive financial advisor to R••••••• B••••••, and P•••• S•••••• acted as exclusive financial advisor to C•••••.”
  • W•••• • C•••Legal adviserconfirmed
    “W•••• • C••• LLP acted as legal advisor to C••••• on the transaction.”
  • W•••••• B•••• • C••••••• L•••••Sell-side adviserconfirmed
    “W•••••• B•••• & Co. acted as exclusive financial advisor to R••••••• B••••••, and P•••• S•••••• acted as exclusive financial advisor to C•••••.”
Side not stated
  • J••• H• J••••••Managementconfirmed
    “J••• H• J••••••, CEO and Board Director of R••••••• B••••••, said, "I look forward to working closely with the leadership and scientific teams – along with the entire organization – to fully realize the Company's potential in drug discovery services.”
  • R••••••• B••••••Targetconfirmed
    “R••••••• B•••••• Announces Closing of Growth Investment from C••••• a•• C•••• E•••••••• O•••••• T•••••••••”
Evidence
“R••••••• B•••••• Announces Closing of Growth Investment from C••••• a•• C•••• E•••••••• O•••••• T•••••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
R••••••• B•••••• Announces Closing of Growth Investment from C••••• a•• C•••• E•••••••• O• | Private Equity Intelligence | DFX